By The RX Index Editorial TeamLast updated: Last verified: Editorial Standards

Medicare GLP-1 Bridge TrOOP: Does the $50 Copay Count Toward Your Part D Cap?

The RX Index is a pricing intelligence and comparison resource for GLP-1 telehealth providers. This guide is educational information — not medical, insurance, legal, or financial advice. For questions about your own coverage, call 1-800-MEDICARE (1-800-633-4227) or your State Health Insurance Assistance Program (SHIP). Next review before the July 1, 2026 launch.

If you saw a headline about Medicare covering weight-loss drugs for $50 a month, you probably felt two things at once: relief, then suspicion. Good instincts. Medicare almost always has a rule hiding in the fine print — and this one trips up a lot of smart people.

Medicare GLP-1 Bridge TrOOP, the short version: No — your $50 Bridge copay does NOT count toward TrOOP (your “true out-of-pocket” total) or your yearly Part D drug cap, which is $2,100 in 2026 and $2,400 in 2027. The Medicare GLP-1 Bridge is a temporary federal program. From July 1, 2026 through December 31, 2027, eligible Medicare Part D members can get Wegovy®, Zepbound® KwikPen, or Foundayo® for weight loss at a flat $50 a month. The reason the $50 doesn’t count: the Bridge sits outside the Part D benefit payment flow, which is what CMS says in its guidance. It’s a parallel program, not a Part D benefit.
Who it’s best for: Part D members with a higher BMI who want a GLP-1 to lose weight and have been priced out at $300–$1,300 a month.
Who it’s not for: people getting a GLP-1 for type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease (a specific type called MASH) — those go through your regular Part D plan instead — or anyone in a plan type the Bridge doesn’t accept.

Even though the $50 doesn’t count toward your cap, it’s still one of the best GLP-1 deals on the table right now — if you qualify. Below we show you exactly why, who qualifies, which drugs count, and what to say to your doctor.

Your three Medicare GLP-1 lanes, side by side

Most confusion clears up the moment you see there are really just three lanes: the Bridge, regular Part D, and cash-pay. Each one costs a different amount, and each one counts (or doesn’t count) toward your Part D cap differently. Find your row.

Your three Medicare GLP-1 lanes — Bridge, regular Part D, and cash-pay: cost, TrOOP credit, who submits, and next step
Your situationYour likely laneWhat you payCounts toward Part D cap? (2026: $2,100 · 2027: $2,400)Who submits / handles approvalYour next step
Wegovy, Zepbound KwikPen, or Foundayo for weight loss, and you meet the Bridge rulesMedicare GLP-1 Bridge$50 / month, flatNoYour doctor submits it; a central processor (Humana) handles approval, claims, and paymentAsk your doctor to start a Bridge request after July 1, 2026
Any GLP-1 for type 2 diabetesRegular Part DYour plan’s cost until you hit the cap ($2,100 in 2026; $2,400 in 2027), then $0YesYour doctor submits any prior authorization; your Part D plan decidesAsk your plan/doctor about the formulary and prior authorization
Wegovy to lower heart-attack/stroke risk (established heart disease)Regular Part DPlan-specificYesYour doctor + your Part D planRoute to Part D, not the Bridge
Zepbound for moderate-to-severe sleep apnea (with obesity)Regular Part DPlan-specificYesYour doctor + your Part D planRoute to Part D, not the Bridge
You have Extra Help and qualify for the BridgeBridgeStill $50NoDoctor + central processorBudget $50/month — Extra Help won’t lower it
You’re not in a qualifying plan typeNot Bridge-eligible yetVariesVariesDependsConfirm your plan type with 1-800-MEDICARE or SHIP
You don’t meet the BMI/health rulesCash-pay or Part D (if another covered reason already fits)Cash price, or your plan cost if coveredNo (if cash)Cash provider, or your doctor + planAsk your doctor if a diagnosed covered reason already applies
You choose cash-pay (Ro, manufacturer direct)Cash-payPublished cash priceNoThe cash providerUse only if the Bridge/Part D path doesn’t fit

Sources: CMS, Medicare GLP-1 Bridge — Information for Medicare Beneficiaries (last modified June 3, 2026) and Information for Part D Plans (last modified May 29, 2026); Medicare.gov and the CMS CY 2026/CY 2027 Part D announcements; Ro pricing page.

Check my GLP-1 cost path

Free, about a minute, no sign-up. Answer a few quick questions and we\u2019ll show you which lane your GLP-1 belongs in \u2014 Bridge, regular Part D, or cash-pay \u2014 and roughly what it\u2019ll cost you.

What does “Medicare GLP-1 Bridge TrOOP” actually mean?

TrOOP stands for “true out-of-pocket costs” — the running total Medicare uses to decide when you’ve hit your Part D drug cap for the year. The reason “Medicare GLP-1 Bridge TrOOP” confuses people is that you need Part D to use the Bridge, but the $50 you pay through the Bridge does not get added to your TrOOP total. The two run on separate tracks.

Think of it like two buckets. Your normal Part D drugs go in the TrOOP bucket. Every dollar in that bucket pushes you toward your cap, and once the bucket is full, your covered drugs cost $0 for the rest of the year. The Bridge is a different bucket sitting next to it. You pay $50, the medicine comes out — but nothing lands in the TrOOP bucket. CMS says it plainly: the Bridge sits “outside the Part D benefit payment flow.”

In one line: you fill a Bridge prescription, you pay $50, and your TrOOP total goes up by exactly $0.

One more thing, since you may have typed it as “troop.” For Medicare drug costs, the word is TrOOP (true out-of-pocket). If you actually meant troop — as in military or veteran coverage — skip ahead to the TRICARE For Life section. We cover that too.

Quick definition you’ll see again: GCPDC = “gross covered prescription drug costs,” the bigger tally of total drug spending. The Bridge’s $245 behind-the-scenes drug price doesn’t count toward that either. See our $245 net drug price guide for the full explanation.

Does the $50 Bridge copay count toward your Part D cap?

No. CMS confirms that no part of the $50 copay counts toward your TrOOP, and the Bridge’s $245 net drug price doesn’t count toward your gross covered drug costs. That means the Bridge can give you a very low price if you qualify, but it will not move you closer to your Part D out-of-pocket cap. It’s a parallel program, not part of your plan.

Let’s be specific about what does and doesn’t count, because this is the question that sends people back to Google five times.

What counts toward your Part D deductible and TrOOP cap: regular copays, Extra Help, Bridge $50, Bridge $245 net price, cash prices, Ro direct pay
What you payCounts toward your Part D deductible?Counts toward TrOOP / your Part D cap?
A regular copay for a covered Part D drugYes (plan-dependent)Yes
Extra Help paying part of a covered Part D drugWhere it appliesYes — certain payments made on your behalf count
Medicare GLP-1 Bridge $50 copayNo — the deductible doesn’t applyNo
The Bridge’s $245 net drug priceNoNo
A cash/discount price you use instead of your planNoNo — Medicare says cash prices don’t count
Ro or manufacturer direct-payNoNo — it’s cash-pay, not Medicare

Source: CMS GLP-1 Bridge FAQs; Medicare.gov drug-cost pages.

The honest catch: if your goal is to fill up your Part D cap so the rest of your medicines go to $0, the Bridge won’t help you get there. Your regular Part D drugs do that job. For the full picture, see our Medicare GLP-1 Bridge out-of-pocket maximum guide.

One heads-up on the cap itself: the number changes each year. For covered Part D drugs, the cap is $2,100 in 2026 and rises to $2,400 in 2027 (the deductible goes from up to $615 in 2026 to up to $700 in 2027). The Bridge $50 counts toward neither year’s cap — but it’s worth knowing the real figure for the year you’re in.

Part D out-of-pocket cap by year: 2026 ($2,100) and 2027 ($2,400), whether the Bridge $50 counts, whether a deductible applies
YearPart D out-of-pocket cap (covered drugs)Does the Bridge $50 count toward it?Does a deductible apply to the Bridge?
2026$2,100NoNo
2027$2,400NoNo

Source: CMS CY 2026 Part D Redesign Program Instructions and CY 2027 Rate Announcement.

So is the $50 still worth it? (Yes — here’s why)

For people who qualify, the Bridge is usually the cheapest legitimate way to get a brand-name GLP-1 for weight loss right now. The trade-off is real — the $50 doesn’t build toward your cap — but because the Bridge sits outside Part D, it hands you a flat $50 from day one, with no deductible to clear first. For most weight-loss shoppers, that math wins easily.

Compare it to what the same drugs cost today if you’re paying yourself:

  • Wegovy pen, cash: about $349/month (and roughly $1,349/month at full list price).
  • Zepbound, cash (LillyDirect self-pay): $299/month for the 2.5 mg dose, $399 for 5 mg, and $449 for the 7.5–15 mg doses — and higher-dose refills can cost more if you miss the program’s refill window.
  • Through Ro, cash: Wegovy pill from $149, Wegovy pen from $199, Zepbound KwikPen from $299, Foundayo from $149 — then higher for ongoing months.

Now look at the Bridge: $50. Same flat price in January or December. No deductible to meet first. Same price whether you’re on a starting dose or a maintenance dose.

Because the price never changes, your total cost is easy to predict:

  • Rest of 2026 (July–December, filled monthly): about $300.
  • A full year (2027, filled monthly): about $600.
  • The entire Bridge window (18 months, July 2026–December 2027): about $900.
That’s roughly what a single month of full-price Wegovy can cost. For the right person, this is a genuinely good deal.

A quick reality check: in national polling, about 56% of GLP-1 users said the drugs were hard to afford, including 1 in 4 who said “very difficult” (KFF). If you’ve been in that group, the Bridge is the relief you’ve been waiting on — as long as you fit the rules.

See what you\u2019d actually pay

Tell us your plan type and your drug, and we\u2019ll map your real monthly cost \u2014 plus what counts (and doesn\u2019t) toward your Part D cap.

Who qualifies for the Medicare GLP-1 Bridge?

To qualify, three things must line up: you’re in an eligible Part D plan, the drug is for weight loss only, and your doctor confirms you meet CMS’s BMI and health rules. One important detail trips people up — CMS uses your BMI at the time you started GLP-1 therapy, not your BMI on the day the paperwork goes in. So losing weight first doesn’t disqualify you.

First, the plan check

You need one of these:

  • A standalone Part D drug plan (PDP), or
  • A Medicare Advantage plan with drug coverage (the coordinated-care kind — HMO, HMO-POS, or local/regional PPO).

These also count: Special Needs Plans (SNPs), employer/union group plans (EGWPs), the LI NET program, and people with both Medicare and Medicaid (dual-eligible) who are in an eligible plan type.

These don’t count unless you also have a standalone PDP: private fee-for-service plans, cost plans, PACE, fallback plans, and religious fraternal benefit plans. Not sure which you have? Call 1-800-MEDICARE or your SHIP.

Then, the health rules

Your doctor picks one of three routes and attests to it. (This comes straight off the official CMS prior-authorization form, including the obesity diagnosis codes.)

Medicare GLP-1 Bridge eligibility routes: BMI at GLP-1 start and qualifying health conditions for each of three routes
RouteBMI when you started the GLP-1Health condition needed
Route 135 or higher (Class 2–3 obesity)None required
Route 230 or higher (Class 1 obesity)Heart failure with preserved ejection fraction, or uncontrolled high blood pressure (over 140/90 despite two BP medicines), or chronic kidney disease stage 3a or worse
Route 327 or higherPre-diabetes, or a past heart attack, or a past stroke, or symptomatic peripheral artery disease

You also must be 18 or older, and the drug has to be used for weight loss with lifestyle changes — structured eating and physical activity — unless activity isn’t safe for you. (That “unless” is in the form, too.)

The “BMI when you started” rule, with a real example

CMS gives this exact scenario: you started a GLP-1 in September 2024 at a BMI of 37, and by July 2026 your BMI is 34. You still qualify under Route 1 — your doctor attests that your BMI was 35 or higher when you began therapy. This protects people who are already succeeding on the medication.

For a full walk-through of the qualification path, see our how to qualify for the Medicare GLP-1 Bridge guide.

What to say to your doctor

“Can you document my BMI from when I first started a GLP-1, and note which Medicare GLP-1 Bridge route I meet?”
Build your prescriber checklist

Answer a few questions about your plan, drug, starting BMI, and conditions. We\u2019ll turn it into a short note you can hand your doctor.

Which GLP-1 drugs and forms does the Bridge cover?

The Bridge covers Foundayo, Wegovy (both the injection and the tablets), and the Zepbound KwikPen — when used for weight loss. Two things surprise people: Zepbound’s single-dose vials and single-dose pens are not included (only the KwikPen is), and popular diabetes GLP-1s like Ozempic and Mounjaro aren’t on the Bridge at all.

Medicare GLP-1 Bridge drug list: what is and is not on the Bridge, and why
✅ On the Bridge (for weight loss)❌ Not on the BridgeWhy
Foundayo tablets (orforglipron)Zepbound single-dose vials and single-dose pensOnly the KwikPen form is included
Wegovy injection, Wegovy HD injection, and Wegovy tabletsOzempic, Mounjaro, RybelsusThese are usually diabetes drugs → they go through Part D, not the Bridge
Zepbound KwikPen (tirzepatide)Any GLP-1 for diabetes, sleep apnea, or MASHThose are Part D-covered medical uses
Compounded semaglutide or tirzepatideThe Bridge is for these FDA-approved brand-name drugs only

Source: CMS GLP-1 Bridge FAQs and the official prior-authorization form (drug list updated April 6, 2026 to add Foundayo and clarify Zepbound KwikPen only).

For the specific questions this table raises, see: Does the Bridge cover the Wegovy pill? — and Does the Bridge cover Zepbound vials?

Why the exact form matters

Your pharmacy bills using the precise package code — the NDC (National Drug Code), basically a barcode for that exact product and size. Saying “Zepbound” isn’t enough; it has to be the KwikPen. If a fill gets rejected, the form or the NDC is often the reason — not your eligibility. CMS publishes the exact codes (handy to bring to your pharmacist), and notes the list can change during the program:

Bridge-listed NDC codes by drug as of June 8, 2026: Foundayo, Wegovy oral and injectable, and Zepbound KwikPen
DrugBridge-listed NDCs (as of June 8, 2026)
Foundayo0002-4178-31; 0002-4503-31; 0002-4794-31; 0002-4803-31; 0002-4839-31; 0002-4953-31
Wegovy (oral + injectable)0169-4525-14; 0169-4505-14; 0169-4501-14; 0169-4517-14; 0169-4524-14; 0169-4415-31; 0169-4404-31; 0169-4409-31; 0169-4425-31; 0169-4572-14
Zepbound KwikPen0002-3566-11; 0002-3555-11; 0002-3544-11; 0002-3533-11; 0002-3522-11; 0002-3511-11

Source: CMS GLP-1 Bridge — Information for Pharmacies and beneficiary FAQ. CMS says this list may be updated during the program.

What to ask the pharmacy: “Can you confirm this is being submitted as a Medicare GLP-1 Bridge drug, and that the NDC matches the Bridge-eligible list?”

Bridge or regular Part D — which lane is your prescription in?

If the GLP-1 is only for weight loss, it goes through the Bridge. If it’s for a condition Part D already covers — type 2 diabetes, sleep apnea, noncirrhotic MASH with moderate-to-advanced scarring, or heart-risk reduction — it goes through your regular Part D plan instead. CMS is clear that people with those diagnoses are not eligible for the Bridge for that drug, even if they’d otherwise meet the weight rules.

That sounds backwards at first, so here’s the simple test: What is the prescription for?

Medicare GLP-1 lane by prescription reason: weight loss to Bridge; diabetes, sleep apnea, heart risk, MASH to regular Part D
Why it’s prescribedYour lane
Weight loss / keeping weight off onlyBridge (if you meet the rules)
Type 2 diabetesRegular Part D
Zepbound for moderate-to-severe sleep apnea (with obesity)Regular Part D
Wegovy to lower heart-attack/stroke risk (established heart disease)Regular Part D
Noncirrhotic MASH with moderate-to-advanced liver scarringRegular Part D

Same drug, different reason

This is the part to get right. Wegovy can be a Bridge drug for weight loss — but a Part D drug if it’s prescribed to reduce heart risk. Zepbound KwikPen can be a Bridge drug for weight loss — but Zepbound for sleep apnea goes to Part D. The medicine is the same. The reason decides the lane.

Why does it matter? Two reasons. First, sending it to the wrong place is the fastest way to get denied. Second, the lanes cost differently — a Part D-covered fill counts toward your cap; a Bridge fill doesn’t. If you have one of these covered conditions, regular Part D may actually be the better deal because it builds toward your cap.

Find my correct GLP-1 lane

The quickest way to avoid a denial is sending the request to the right place the first time.

Does Extra Help (the low-income subsidy) lower the $50?

No. CMS says Extra Help — also called the Low-Income Subsidy, or LIS — does not apply to the Bridge copay. This matters a lot if you usually pay just a few dollars for your prescriptions, because on the Bridge you’d still owe the full $50 per month.

Extra Help normally lowers your Part D premiums, deductible, and copays. But the Bridge sits outside normal Part D, so that help doesn’t reach it. For someone on a tight, fixed income, $50 can still be a real hurdle — and we’re not going to pretend otherwise.

If $50 a month is too much, here’s what we’d do, in order:

  1. Call 1-800-MEDICARE or your SHIP and ask about your options.
  2. Ask your doctor whether a diagnosed Part D-covered reason already applies to your prescription — like type 2 diabetes, a covered sleep-apnea use, noncirrhotic MASH with moderate-to-advanced scarring, or an approved heart-risk use. Those run through regular Part D, where Extra Help does apply.
  3. Talk to a pharmacist about lower-cost paths for your situation.
We can’t see your benefits or promise what you’ll pay — only Medicare and your plan can confirm that. But those three calls usually surface the answer.

How do you actually get it? (Step by step, plus the form decoded)

You don’t sign yourself up. Starting July 1, 2026, your doctor submits a prescription and a prior-authorization request — and a pharmacy claim has to be tried and denied first so the system routes it to the Bridge. As of now (June 2026), there’s nothing for you to do yet; CMS says the full process details land closer to launch. For the full application walk-through, see our Medicare GLP-1 Bridge application process guide.

“Prior authorization” (often shortened to PA) just means the program approves the drug before it’s covered. Here’s the path:

  1. Confirm your plan type qualifies (PDP or Medicare Advantage with drug coverage, etc.).
  2. Your doctor confirms the reason — weight loss vs. a covered medical use.
  3. Confirm the drug and form are Bridge-eligible (for example, Zepbound KwikPen).
  4. The pharmacy submits a claim that gets denied through the Bridge billing system — this is a required step, not a problem.
  5. Your doctor submits the PA through CoverMyMeds (or by fax once CMS posts the number).
  6. If approved, you fill it and pay $50.
  7. You track it separately — it won’t show up in your Part D cap progress.

Four pharmacy details that matter to you

These come straight from CMS’s pharmacy guidance, and they answer the follow-up questions people ask most:

  • 28-day or 30-day fills only — the Bridge does not cover 90-day supplies.
  • The $50 copay is not eligible for the Medicare Prescription Payment Program (the program that lets you spread Part D costs across the year). The Bridge $50 sits outside it.
  • You should hear back within 72 hours of the prior-authorization request — the prescriber and patient are notified whether it’s approved or denied.
  • After your first approved fill, refills don’t need a new PA — unless you switch from one covered Bridge GLP-1 to a different one.

What’s actually on the CMS form (so you know it’s real)

We pulled the official CMS prior-authorization form so you’d recognize the real thing. A few details worth knowing:

  • Submitting is restricted to your prescriber — CMS literally tells beneficiaries to have their physician submit it.
  • Electronic requests go through CoverMyMeds.
  • A central processor runs all of this behind the scenes. CMS named Humana as that processor (it also runs Medicare’s LI NET program).
  • There must be a denied pharmacy claim sent to the Bridge billing codes — BIN 028918 and PCN MEDDGLP1BRbefore your doctor sends the PA.
  • The fax line on the current form is still a placeholder (“1-800-###-####”), so the real number hasn’t been published yet.

For a full walk-through of the form itself, see our Medicare Bridge prior-authorization form guide.

A warning worth taking seriously: there is no beneficiary sign-up, no enrollment fee, and no website that “registers” you for the Bridge. If a site or a caller asks you to pay to enroll, or pressures you for your Medicare number to “lock in your $50,” that’s a red flag. For anything real, call 1-800-MEDICARE or your SHIP. The Bridge doesn’t change your normal Part D appeal rights.

What to say to your doctor

“I’m trying to figure out whether my prescription should go through the Medicare GLP-1 Bridge or my regular Part D plan. It’s prescribed for [weight loss / diabetes / heart-risk / sleep apnea]. Can you document the reason, my BMI when I started, the exact drug form, and send the request to the right place?”

If the Bridge is the right fit, one extra ask helps the pharmacy route it correctly: have your prescriber include an obesity diagnosis code (the E66 family) and write “SEND TO BRIDGE FOR WEIGHT MANAGEMENT” on the prescription note.

What if you have TRICARE For Life or military retiree coverage?

If you meant “troop” — as in military retiree coverage — here’s your answer: TRICARE For Life members can use the Bridge only if they’re also enrolled in a Bridge-eligible Medicare Part D plan and meet the same prior-authorization rules. TRICARE For Life by itself is not a shortcut around the Bridge requirements.

So the same checklist applies: eligible Part D plan type, weight-loss reason, BMI/health route, and your doctor’s PA. If you’re juggling VA, TRICARE, Part D, and the Bridge, don’t assume the rules are interchangeable — they’re not. Ask which payer is actually being billed before you fill anything, so you’re not surprised by the cost.

What if you don’t qualify for the Bridge?

Your best next step depends on why you don’t qualify. If your GLP-1 is for a covered medical reason, chase regular Part D coverage. If you’re simply outside the Bridge rules and still want treatment, cash-pay FDA-approved options exist — but they don’t count toward any Medicare deductible or cap, and they cost more than $50.

  • Not eligible because of your plan type? Don’t pay cash yet. Call 1-800-MEDICARE or your SHIP — you may be able to change plans during open enrollment.
  • Not eligible because of your diagnosis? Ask your doctor whether a diagnosed Part D-covered reason already applies — that routes you to regular Part D, where your costs do count toward your cap.
  • Not eligible because of the drug or form? Ask whether a Bridge-covered form is medically appropriate for you.
  • Not eligible, and you want to start now anyway? Cash-pay is your lane. See below.
A note before you click anything: Cash-pay is not the Medicare GLP-1 Bridge. It is not billed to Medicare, and it does not count toward your Part D deductible or cap. Use it only if the Bridge or regular Part D doesn’t fit — or you simply choose not to use Medicare for this. And if you do qualify for the Bridge, the Bridge’s $50 beats every cash price below. We’d rather you save the money.

Disclosure: if you start treatment through a provider we link to, we may earn a commission. That never includes the Medicare Bridge, and it doesn’t change the facts on this page.

For people who don’t qualify and want a brand-name FDA-approved GLP-1, Ro is a reasonable cash-pay option. It carries the same brand-name drugs the Bridge covers — Wegovy (pill and pen), Zepbound KwikPen, and Foundayo — and prices its medications to match LillyDirect, NovoCare, and TrumpRx. Ro’s Body membership starts at $39 for the first month, then as low as $74/month with an annual plan paid upfront (medication is billed separately), and it includes a free insurance checker and concierge support for non-government insurance. One honest limitation: Ro says it currently can’t help coordinate GLP-1 coverage for government plans like Medicare, so Medicare members would be using Ro’s cash-pay options outside the Bridge. (Pricing verified June 8, 2026; confirm current rates on Ro before you commit.)

Compare cash-pay FDA-approved options → (sponsored affiliate link, opens in a new tab)

Only if the Bridge or regular Part D isn’t a fit. Current self-pay prices and what’s included. Sponsored link.

What happens after the Medicare GLP-1 Bridge ends?

The Bridge is temporary — it’s scheduled to run through December 31, 2027. It was originally set to end in 2026, then extended. CMS says the extension lets it gather more data on GLP-1 use ahead of potential future coverage through the BALANCE Model in Part D. In other words, the $50 path is not guaranteed to be permanent.

  • The current end date is December 31, 2027. Plan around that, not around “forever.”
  • The Part D cap rises to $2,400 in 2027 (from $2,100 in 2026), and the deductible to up to $700 — so if you also take regular Part D drugs, your yearly math shifts a bit.
  • Review your plan during open enrollment. Coverage rules and formularies change every year.
  • Separately, a negotiated Medicare price cut on some GLP-1s has been reported to start in 2027 — but the details are still settling, so treat the specifics as not-yet-final.

We re-check all of this on a schedule, and we’ll update this page when CMS does.

What we verified (and where)

We don’t expect you to take “trust us” for an answer — especially on Medicare. Here’s exactly what we checked, when, and which source controlled it.

Medicare GLP-1 Bridge verification table: fact verified, current answer, primary source, and date last checked
What we verifiedCurrent answerSourceLast checked
Program datesJuly 1, 2026 – December 31, 2027CMSJune 8, 2026
Copay$50 per monthly supplyCMSJune 8, 2026
Counts toward TrOOP?NoCMSJune 8, 2026
Bridge net drug price$245 (doesn’t count toward GCPDC)CMSJune 8, 2026
Extra Help / LISDoes not lower the $50CMSJune 8, 2026
Covered drugsFoundayo, Wegovy (injection + tablets), Zepbound KwikPenCMSJune 8, 2026
Excluded Zepbound formsSingle-dose vial and single-dose penCMSJune 8, 2026
BMI/health routesBMI 35 / 30 + condition / 27 + conditionCMS PA formJune 8, 2026
Central processorHumana (also runs Medicare’s LI NET)CMSJune 8, 2026
Prior-auth detailsCoverMyMeds; BIN 028918, PCN MEDDGLP1BR; denied claim required first; fax = placeholderCMS PA formJune 8, 2026
Fill length28-day or 30-day fills only (no 90-day)CMS pharmacy guidanceJune 8, 2026
Medicare Prescription Payment Program$50 copay not eligibleCMS pharmacy guidanceJune 8, 2026
PA response timePrescriber/patient notified within 72 hoursCMS pharmacy guidanceJune 8, 2026
Paper claims / direct reimbursementNot acceptedCMSJune 8, 2026
Coupons / discount programsMay not be applied to Bridge claimsCMSJune 8, 2026
2026 Part D deductible / capUp to $615 / $2,100Medicare.gov + CMSJune 8, 2026
2027 Part D deductible / capUp to $700 / $2,400CMS CY 2027 Rate AnnouncementJune 8, 2026
Ro cash-pay (for non-qualifiers)Membership from $39, then as low as $74/mo annual; meds billed separatelyRoJune 8, 2026
Primary sources: CMS — Medicare GLP-1 Bridge, Information for Medicare Beneficiaries, Information for Part D Plans, and Information for Pharmacies (cms.gov); CMS — Medicare GLP-1 Bridge Prior Authorization Request Form; CMS — CY 2026 Part D Redesign Program Instructions and CY 2027 Rate Announcement; Medicare.gov drug-cost pages; KFF — What to Know About the BALANCE Model… and the Medicare GLP-1 Bridge; Ro pricing page. Manufacturer cash prices (NovoCare, LillyDirect) verified June 2026.

How we made this guide

The RX Index is a pricing intelligence and comparison resource for GLP-1 telehealth providers. For this guide, we treated CMS and Medicare.gov as the controlling sources for every Medicare rule, read the official prior-authorization form and pharmacy guidance to map the real application path, and used provider pages only for the non-Medicare cash-pay facts. We did not paraphrase another publisher’s article — we went to the primary documents and translated them into plain language.

A few promises about how we work: we don’t list a “medically reviewed by” line unless a qualified clinician actually reviewed the page, and we haven’t put a fake reviewer or made-up author on it. We read real Medicare-forum posts to understand where people get confused, but we never use forum chatter as proof of a medical or coverage rule. And we don’t rank providers on this page, because this is a Medicare-information page — not a product comparison. If you eventually click a cash-pay provider link and start treatment, we may earn a commission; that never includes the Bridge, and it doesn’t shape the facts here.

Frequently asked questions

Is the Medicare GLP-1 Bridge really $50 a month?
Yes, if you qualify. CMS says eligible beneficiaries pay a $50 copay per monthly supply — but the drug, plan type, weight-loss reason, BMI/health route, and prior authorization all have to line up first.
Does the $50 Bridge copay count toward TrOOP?
No. CMS states that no part of the $50 copay counts toward your true out-of-pocket (TrOOP) total under your Part D plan, because the Bridge runs outside the Part D benefit.
Does the $50 count toward my Part D deductible?
No. Since Bridge drugs sit outside the normal Part D payment flow, your Part D deductible does not apply to the $50 copay.
Does Extra Help lower the Bridge copay?
No. CMS says the Low-Income Subsidy (Extra Help) does not apply to the Bridge copay, so you’d still owe the full $50 per monthly supply.
Can I get a 90-day supply through the Bridge?
No. CMS pharmacy guidance says only 28-day or 30-day fills are covered through the Bridge — not longer supplies.
Can I use the Medicare Prescription Payment Program for the $50 copay?
No. The $50 Bridge copay is not eligible for the Medicare Prescription Payment Program, since the Bridge operates outside the Part D benefit.
Can I pay cash now and get reimbursed by the Bridge later?
No. CMS says paper claims and direct member reimbursements are not accepted, and coupons or discount programs may not be applied to Bridge claims. To get the $50 price, the claim has to run through the Bridge process.
Who runs the Medicare GLP-1 Bridge?
CMS runs the program and named Humana — which also administers Medicare’s LI NET program — as the central processor that handles prior authorization, claims, and pharmacy payment. Your own doctor still submits the request.
Is Zepbound covered by the Bridge?
Only the Zepbound KwikPen is on the Bridge list. CMS excludes Zepbound single-dose vials and single-dose pens from the program.
Is Ozempic covered by the Medicare GLP-1 Bridge?
No. Ozempic isn’t on the Bridge’s weight-loss drug list. It may be covered through regular Part D for a covered use like type 2 diabetes, depending on your plan.
Can I use the Bridge if I have diabetes?
If the GLP-1 is prescribed for type 2 diabetes, CMS says it goes through your regular Part D plan, not the Bridge. The Bridge is only for GLP-1s prescribed for weight loss when you don’t have a Part D-covered diagnosis for that drug.
When does the Medicare GLP-1 Bridge start and end?
It runs from July 1, 2026 through December 31, 2027. CMS says the extension gives it more data on GLP-1 use ahead of potential BALANCE coverage in Part D.
What is the Part D cap in 2027?
For covered Part D drugs, the out-of-pocket cap is $2,100 in 2026 and $2,400 in 2027. The Bridge $50 copay counts toward neither year’s cap.
Is it “TrOOP” or “troop”?
For Medicare drug costs, the term is TrOOP — true out-of-pocket. If you meant “troop” as in TRICARE For Life, those members can use the Bridge only if they’re also in an eligible Part D plan and meet the prior-authorization rules.
Still not sure which GLP-1 program is right for you? We’ll map your situation to the Bridge, regular Part D, or a cash-pay option, and tell you exactly what to ask next. No sign-up, no pressure — just a clear answer.
Take our free 60-second matching quiz

Bridge, regular Part D, or cash-pay \u2014 with exactly what to ask next. No sign-up.

Last verified: . Medicare rules, CMS guidance, and program details can change. We re-check this page regularly and update this date when a source changes. For questions about your own coverage, call 1-800-MEDICARE (1-800-633-4227) or contact your State Health Insurance Assistance Program (SHIP).